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We have measured maximal oxygen consumption (V˙O2,max) of mice lacking one or two of
the established mouse red-cell CO2 channels AQP1, AQP9, and Rhag. We intended to
study whether these proteins, by acting as channels for O2, determine O2 exchange in the
lung and in the periphery. We found that V˙O2,max as determined by the Helox technique is
reduced by∼16%, when AQP1 is knocked out, but not when AQP9 or Rhag are lacking.
This figure holds for animals respiring normoxic as well as hypoxic gas mixtures. To see
whether the reduction of V˙O2,max is due to impaired O2 uptake in the lung, we measured
carotid arterial O2 saturation (SO2) by pulse oximetry. Neither under normoxic (inspiratory
O2 21%) nor under hypoxic conditions (11% O2) is there a difference in SO2 between
AQP1null and WT mice, suggesting that AQP1 is not critical for O2 uptake in the lung.
The fact that the % reduction of V˙O2,max is identical in normoxia and hypoxia indicates
moreover that the limitation of V˙O2,max is not due to an O2 diffusion problem, neither
in the lung nor in the periphery. Instead, it appears likely that AQP1null animals exhibit a
reduced V˙O2,max due to the reduced wall thickness and muscle mass of the left ventricles
of their hearts, as reported previously. We conclude that very likely the properties of the
hearts of AQP1 knockout mice cause a reduced maximal cardiac output and thus cause
a reduced V˙O2,max, which constitutes a new phenotype of these mice.
Keywords: aquaporin 1, Rhesus-associated glycoprotein, aquaporin 9, maximal oxygen consumption, knockout
mice, arterial oxygen saturation, cardiac function of the heart of aquaporin-1-deficient mice
INTRODUCTION
Molecular dynamics simulations have shown that AQP1 and AQP4 may conduct CO2 and O2
through their central pore (Hub and de Groot, 2006; Wang et al., 2007; Wang and Tajkhorshid,
2010). This is likely to be also true for some other aquaporins such as AQP9. Experimental
evidence for a physiologically meaningful conduction of CO2 by these three proteins has indeed
been repeatedly reported (Endeward et al., 2006a; Musa-Aziz et al., 2009; Itel et al., 2012; Geyer
et al., 2013). In addition both, molecular dynamics simulations and experimental evidence, have
shown that Rhesus proteins conduct CO2 (Endeward et al., 2006a,b, 2008; Musa-Aziz et al., 2009;
Hub et al., 2010). However, in our view clear experimental evidence for a physiologically relevant
conduction of O2 does not exist for any of these gas channels.
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It was our aim in this paper to study the role of these
gas channels in systemic O2 transport by measuring maximal
oxygen consumption in mice, which had one or two of these
channels knocked out. We wanted to test, whether absence of
one or two of these channels results in a diffusion problem
that limits oxygen uptake. We chose AQP1null, Rhagnull, and
AQP9null animals, because these three proteins occur in the red
blood cell membrane of the mouse and because all three of them
have been shown to act as CO2 channels either in human red
cells (Endeward et al., 2006a,b, 2008) or in artificial expression
systems (Musa-Aziz et al., 2009; Geyer et al., 2013). It should be
appreciated that the principle of our measurement implies that
not only lack of potential O2 channels in the red cell membrane,
but also lack of such channels in lung tissue and in the tissues of
peripheral organs, especially skeletal muscle, could be involved in
a limitation of maximal oxygen consumption.
We propose from our data that lack of the three gas channels
does not impair oxygen exchange in lung and tissues. However,
lack of AQP1, which is associated with a significant reduction
of maximal oxygen consumption, likely causes this effect via a
reduced maximal cardiac output of the AQP1 knockout animals.
In a preceding paper (Al-Samir et al., 2016) we have reported that
the left ventricle of the hearts of AQP1-deficent mice has thinner
walls than WT mice along with a reduced capillary density.
METHODS
Animals
Breeding pairs of heterozygous AQP1 KO mice were kindly
provided by Dr. Alan S. Verkman (San Francisco, USA; Ma
et al., 1998). They were intercrossed to obtain homozygous AQP1
KO mice and WT littermate controls. AQP9 KO mice were
those described by Rojek et al. (2007), Rhagnull mice were those
described in Goossens et al. (2010). AQP1/Rhag double KO mice
were obtained by intercrossing the two types of KO mice. All
strains were occasionally intercrossed with Bl6 from the central
animal facility of Hannover Medical School. For PCR genotyping
of AQP1-knockout mice we used the DNA from tail snippets and
specific the primers
AQP1 W: AAG TCA ACC TCT GCT CAG CTG GG
AQP1 Neo: CTC TAT GGC TTC TGA GGC GGA AAG
AQP1 KO: ACT CAG TGG CTA ACA ACA AAC AGG
in one single PCR reaction.
For PCR genotyping of AQP9-knockout mice with DNA
isolated from tail snippets specific primers were used in one single
PCR reaction:
F: 5′-AAC TGG GGA TAG TGG GAT TCA AAG A-3′ for
AQP9 WT
R: 5′-GCC ACT AGC CAT GTG TTG GTA TTT C-3′ for
AQP9 WT and KO
F: 5′-GTG CTA CTT CCA TTT GTC ACG TCC T-3′ for
AQP9 KO.
For PCR genotyping of Rhag-knockout mice with DNA isolated
from tail snippets specific primers were used in two separate
runs:
RhAG WT-F: 5′-CCA TCT CTC CAG CCT AGC AAT TTT
C-3′
RhAGWT-R: 5′-AAG TCA GGA AAG AGT CAT TGC ATG
G-3
RhAGKO-F: 5′-TGCTATGACCATTGGAAGCATTGC-3′
RhAG KO-R: 5′-ATT GCA TCG CAT TGT CTG AGT
AGG-3′
The absence of the proteins AQP1, AQP9, and Rhag, respectively,
has been demonstrated in the single KOmice by Ma et al. (1998),
Rojek et al. (2007), and by Goossens et al. (2010).
The mice used in this study had an average weight
of 26–31 g and comprised about equal numbers of males
and females. For the measurements of resting and maximal
oxygen consumption, the groups were weight-matched. Animal
experiments were approved by the Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit (No. 33.12-
42502-04-12/0973).
Measurement of Animal Oxygen
Consumption
Measurements of animal oxygen consumption were done on
conscious mice. Oxygen consumption V˙O2 was measured
under two conditions, firstly under “resting” conditions using
air at room temperature as the inspiratory gas (V˙O2,rest),
secondly under conditions maximizing V˙O2 by using either a
(normoxic) mixture of 79% He with 21% O2 (Helox) cooled
down to 4◦C, yielding normoxic V˙O2,max, or a (hypoxic)
mixture of 79% He with 11% O2 and 10% N2 at 4◦C and
yielding hypoxic V˙O2,max. While the measurement using air
represents the classical open system for V˙O2 determination,
which measures gas flow together with inflowing and outflowing
O2 concentrations, the measurement using He/O2 follows
the same principle but maximizes V˙O2 of the animals by
withdrawing heat from their lungs. The increased heat loss is
caused by the employed gas mixture of 79% He and O2,which
conducts heat 4 times more effectively than air (Rosenmann
and Morrison, 1974). This heat loss causes a drastic increase
in V˙O2, initiated by the thermoregulatory system aiming to
maintain core body temperature. Comparisons with protocols
for maximal physical exercise and other techniques have shown
that this elevated V˙O2 indeed represents the maximal oxygen
consumption achieved by the animals, V˙O2,max, which has a
value 5–7 times higher than the basal V˙O2 of mice of ∼0.03
ml O2/g body weight/min (Segrem and Hart, 1967; Rosenmann
and Morrison, 1974; Chappell, 1984; von Engelhardt et al.,
2015).
The basic experimental setup for both types of measurement
is illustrated in Figure 1. The setup shown allowed us to measure
V˙O2 of one mouse that was placed into one of the two respiratory
chambers shown. The second chamber was used to obtain a
reference gas value. Respiratory chamber dimensions were 15.5
× 8.5× 10.5 cm. The two pumps drew gas from the gas reservoir
at a constant flow rate of 35 l/h through each of the chambers,
one with and one without a mouse. The valves of the flow
multiplexer (MUX, Sable Systems, North Las Vegas, NV 89032
USA) were controlled by a PC. This provided values of flow
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FIGURE 1 | Experimental set-up for measurement of maximal oxygen consumption. Pumps draw gas from the gas reservoir through the respiratory
chambers and from there via the multiplexer through a water condensation trap and through the flow meter into the oxygen analyzer. For V˙O2, max determination, the
gas reservoir contains 21% oxygen/rest He, and the gas reservoir and respiratory chambers are placed into a cold room at 4◦C. For resting V˙O2 determination, the
gas reservoir contains air, and the entire set-up is placed in room air at 21◦C. The empty chamber serves as a control of the inspiratory gas. Usually a third respiratory
box was mounted in parallel to the two boxes shown, containing another animal. In this case, the three boxes contained a WT mouse, a KO mouse and no animal,
respectively. The gas coming from the empty box was used as a reference gas indicating the O2 concentration in the gas reservoir.
rates (MKS Instruments, Munich, Germany; Model: 035CC-
01000SVS008) and oxygen concentrations of the outflowing gases
(FoxBox; Field Oxygen Analysis System; Sable Systems, North
Las Vegas, NV 89032 USA), alternating every 90 s between the
two boxes. The gas coming from the empty chamber served
as a reference gas for the O2 concentration of air or the He-
O2 mixture in the reservoir, respectively, i.e., of the inspiratory
gas. The flow meter was calibrated by flushing it at known flow
rates either with air or with the suitable helium mixture. V˙O2-
values were determined from the difference in O2 concentrations
between the gases leaving the two chambers, multiplied by
the flow rate of the gas leaving the chamber occupied by the
mouse. V˙O2 was normalized for standard (STPD) conditions
(0◦C, dry).
For simultaneous determination of V˙O2 in two mice, a third
respiratory box was arranged in parallel to the two boxes
indicated in the figure. Then, the flow multiplexer alternated
between the three boxes and the gas coming from the empty
chamber again served as a reference gas. The same gas flow
was sucked continuously from the reservoir through all three
chambers. Usually, V˙O2 was measured in parallel for one
KO and one WT mouse of similar body weight. Measuring
periods for V˙O2 determinations were 45 min, but in the
V˙O2,max measurements the maximum was usually reached after
a few minutes. It should be noted that the measurements with
room air at 21◦C were carried out substantially below the
thermoneutrality temperature of mice (28◦C; Hoevenaars et al.,
2014).
In vivo Measurement of Arterial Oxygen
Saturation and Heart and Respiratory Rate
Carotid artery oxygen (SO2) saturations together with heart rates
(HR) and respiratory rates (RR) were measured in vivo with
a MouseOX Plus pulse oxymeter (Starr Life Sciences Corp.,
Oakmont, PA 15139 USA) using ThroatClip sensors size M or S
depending on animal size. Data were recorded with the MousOX
Plus premium monitoring software. Neck and throat of the
animals where shaved to ensure optimal contact of the sensors.
The carotid SO2 measurements were performed only on animals
respiring 79% He with 21 or 11% O2 at 4◦C, using the same
setup as employed for V˙O2,max experiments (Figure 1). SO2, HR,
and RR were recorded continuously for 20 min for each animal
studied. Due to the greater agility of the animals respiring air at
21◦C, the sensor did not remain in a stable position, therefore SO2
measurements under resting conditions could not be performed
reliably.
Statistical Treatment
The results of V˙O2,max and SO2 showed without exception normal
distribution when tested according to D’Agostino & Pearson. All
pairs of data fromWT vs. KO animals were subjected to Student’s
t-test (unpaired). The software used for both tests was GraphPad
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Prism 6.01 (GraphPad Software, Inc., La Jolla, California, USA).
Statistical significances were calculated for each pair of WT/KO
measurements. N-values given in the tables refer to number of
animals studied.
RESULTS
Resting Oxygen Consumption of
Conscious Mice
Specific resting oxygen consumption of WT mice as measured
under exposure of the animals to air at 21◦C varies between
0.066 and 0.072ml O2/g body weight/min for the different mouse
strains listed in Table 1 (2nd column). These values, as already
discussed above, are about twice the expected basal V˙O2-value
for mice of∼0.03 ml/g/min (Segrem and Hart, 1967; Rosenmann
and Morrison, 1974; von Engelhardt et al., 2015). The higher
V˙O2 may be caused by two factors: (1) the temperature of the
measurement, 21◦C, is markedly below thermoneutrality, which
causes an enhanced metabolism, and (2) the tendency of the
animals to exhibit low to moderate physical activity by moving
around in their cages (Figure 1). Comparing the resting V˙O2-
values of the four mouse strains, it is seen that in two cases,
Rhag KO and AQP9 KO, resting V˙O2 is not significantly different
between KO and WT, but in the other two cases, AQP1 KO and
AQP1-Rhag double KO, V˙O2 is significantly lower in KO mice
compared to WT mice. This seems to point to a special property
of the AQP1-KO strain.
Maximal Oxygen Consumption of
Conscious Mice
As described in Methods, the principle employed here to obtain
V˙O2,max is to withdraw heat from the animals via their lung. This
is achieved by exposing the animals not only to an environment
of 4◦C but in addition letting them respire a gas mixture
containing 79% Helium (plus either 21 or 11% O2), which is
also cooled down to 4◦C. The excellent heat conduction by
He greatly accelerates heat loss and induces an increase in the
animals’ V˙O2 to the maximum. For normoxic conditions, the
3rd column of Table 1 shows the results for V˙O2,max as obtained
by inspiration of Helox at 4◦C. It is apparent that only in the
case of AQP1-deficient mice, AQP1-KO and AQP1-Rhag double
KO, the V˙O2,max-value is markedly and significantly lower in KO
than in WT mice, with differences of 16% in both animal strains.
Neither Rhag-KO nor AQP9-KO show a difference to WT. We
conclude that lack of AQP1 significantly reduces the maximal
oxygen consumption under normoxic conditions. Compared to
their basal V˙O2 of ∼0.03 ml O2/g/min, the WT animals exhibit a
4.5–5.5 times elevated V˙O2,max, which is in excellent agreement
with the literature (Segrem and Hart, 1967; Rosenmann and
Morrison, 1974; Lechner, 1978; Chappell, 1984).
Under hypoxic conditions, V˙O2,max is in general drastically
reduced to 60–65% of the normoxic values due to the hypoxia
induced by 11% O2 in the inspired gas. A significant difference
between KO- andWT-values is only seen in the case of the AQP1-
KO mouse, where V˙O2,max is 15% lower in KO than in WT mice.
A similar difference in AQP1-Rhag double-KO mice does not
reach statistical significance. In Rhag-KO and AQP9-KO mice
there is no difference compared to the respective WT animals.
We conclude that, under hypoxia, lack of AQP1 causes a very
similar reduction in V˙O2,max as we see it in normoxia. The two
other gas channels are without effect.
Heart Rates and Carotid Artery Oxygen
Saturations of Conscious Mice under
Conditions of Maximal Oxygen
Consumption
Table 2 gives the results of the pulse oximetric determinations
of carotid arterial SO2, HR, and RR. In normoxia (2nd and 3rd
columns), SO2 has a normal value of 97% both in WT and
KO mice. Heart rates are greater than 700 min−1, indicating
a maximally increased cardiac activity under Helox respiration
(Hoit and Walsh, 2002, p. 284; Segrem and Hart, 1967; Kramer
et al., 1993; Desai et al., 1997; Schuler et al., 2010, and
personal communication by Beat Schuler). There is no significant
difference between HR of KO and WT mice. The same holds for
the RR-values.
The 4th and 5th columns of Table 2 give the oximetric results
under hypoxia. Arterial SO2 is markedly reduced to about 65%,
but there is again no difference between KO and WT. Likewise,
values of HR and RR are not different between KO and WT;
they are also not different from the values under normoxia. In
conclusion, AQP1 deficiency does not seem to affect arterial
oxygen saturation and heart as well as respiratory rate.
DISCUSSION
Can the Hypoxic Reduction of V˙O2,max in
Wildtype Animals under Hypoxia Be Fully
Explained by the Reduced Arterial SO2?
Since all WT animals can be assumed to have normal cardiac
function, it seems likely that the drastically reduced V˙O2,max seen
under hypoxia is solely due to the markedly reduced arterial
SO2 observed in this condition (Table 2). We discuss in this
paragraph, whether this assumption is plausible in view of the
existing literature. Judged from the heart rates of theWT animals
seen in Table 2, it appears that cardiac activation is close to
maximal and identical under normoxia and hypoxia. If indeed
cardiac output is identical for WT under normoxia and hypoxia,
the reduction of O2 consumption must be exclusively due to a
reduced oxygen extraction form arterial blood under hypoxia. On
average, WT animals under hypoxia (Table 1) show a V˙O2,max
amounting to 63% of V˙O2,max under normoxia. From the arterial
O2 saturations given in Table 2 for WT under normoxia and
hypoxia, it can be estimated that the diminished O2 consumption
under hypoxia is fully explicable by the diminished arterial
O2 saturation in hypoxia: if mixed venous SO2 is taken to be
about 10% in both normoxic and hypoxic animals, arterio-
venous SO2 differences of 87% in normoxia and of 55% in
hypoxia are calculated. Indeed, 55 turns out to be 63% of 87,
indicating that the difference in O2 extraction fully explains the
difference in V˙O2,max. A number of 10% for mixed venous SO2
is realistic in view of measurements performed under maximal
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aerobic exercise in normoxia and hypoxia in goats, which
yielded mixed venous SO2-values between 9 and 4.4% (Crocker
and Jones, 2014). Although it cannot be excluded that in the
present measurements mixed venous SO2 is somewhat different
in normoxia and hypoxia, a deviation of, say, 5% from the
assumed venous SO2 would only slightly affect this estimate. We
conclude that the reduced V˙O2,max can be satisfactorily explained
by the diminished arterial SO2 together with a reasonable value
for mixed venous SO2.
Lack of AQP1, But Not of Rhag and AQP9,
Reduces V˙O2,max—Possible Mechanisms
Table 1 shows that lack of AQP1 reduces V˙O2,max by about
15%, under both normoxia and hypoxia. This constitutes a
new phenotype of AQP1-deficient mice, and might be caused
by either reduced cardiac output or impaired gas exchange in
AQP1-deficient mice. Although in our view there is no clear
experimental evidence for a role of AQP1 in O2 transport
across membranes, it has been shown by molecular dynamics
simulations that AQP1 constitutes a channel for O2 as it does for
CO2 (Wang et al., 2007). This fact has been invoked to explain
experimental data on the interrelationship between AQP1 and
HIF (hypoxia inducible factor) expression (Echevarría et al.,
2007).
AQP1 is almost universally present in the capillaries of the
body, notably in the lung, the heart and skeletal muscle (Nielsen
et al., 1993; Rutkovskiy et al., 2013). It is also present in the red
blood cell membrane, where is has been shown to act as a CO2
channel (Endeward et al., 2006a). If AQP1 contributed to O2
exchange in red blood cells, in the lung and in the periphery,
it would be conceivable that lack of AQP1 is associated with
retarded O2 diffusion in the lung as well as in the periphery. We
have shown previously (Al-Samir et al., 2016) that a diffusion
problem does not exist in the anesthetized AQP1-deficient mouse
under conditions of a low rate of O2 consumption, neither in the
lung nor in the periphery. The likelihood that a diffusion problem
becomes apparent, however, increases with increasing O2 flow,
i.e., O2 consumption, and with decreasing gradients of pO2
across the lung and/or peripheral diffusion barriers. This means,
a diffusion limitation is most likely to show up when (a) V˙O2
is maximal and (b) the animal inspires a hypoxic gas mixture.
Therefore, we have measured in this study V˙O2 under conditions
maximizing the animals’ metabolism and under hypoxia.
In view of recent evidence on the morphological and
functional properties of the hearts of AQP1-deficient mice
(Montiel et al., 2014; Al-Samir et al., 2016), we propose here that
the reduced maximal V˙O2 of these mice (Table 1) is due to a
reducedmaximal cardiac output. In the following, we will discuss
the available evidence for impaired gas exchange vs. reduced
cardiac output.
Effect of Hypoxia on V˙O2,max Argues Against a
Diffusion Problem
It is characteristic for a limitation by diffusion that the limitation
is aggravated when the O2 partial pressure (pO2) gradient that
drives the diffusion process is reduced. This happens in the
lung as well as in the periphery when the animals are exposed
to hypoxia. Our results do not show such a limitation. Under
hypoxia, when alveolar pO2 is cut down to roughly one half,
the relative reductions of V˙O2,max (Table 1) caused by the lack
of AQP1 (15%, 13%) are identical to those observed under
normoxia (16%, 16%). This clearly argues against an O2 diffusion
problem due to the lack of AQP1. This argument applies to
pulmonary as well as peripheral gas exchange.
No Limitation of Pulmonary O2 Exchange Apparent
from Arterial O2 Saturation
For pulmonary gas exchange, this conclusion is supported most
directly by the data of Table 2. The arterial oxygen saturations
obtained by pulse oximetry during conditions of V˙O2,max show
no difference between WT and KO animals, both in normoxia
and hypoxia. Thus, even under conditions of maximal challenge
of O2 diffusion by V˙O2,max in combination with hypoxia, the
blood passing though the lung is equally (and fully) equilibrated
with alveolar pO2 in KO as well as in WT mice. These data rule
out a limiting role of O2 diffusion in the lung. It will be desirable
to confirm in the future the normal diffusion properties of the
lungs of AQP1-KO mice by directly measuring their diffusion
capacities (Fallica et al., 2011). As just discussed, our data also
TABLE 1 | Results of V˙O2 measurements in KO and WT mice (in ml O2/g/min).
Normoxia Hypoxia Body weight
V˙O2, rest(air) V˙O2, max (Helox) V˙O2, max (He, 11%O2)
AQP1 WT 0.066 ± 0.011 (13) 0.165 ± 0.016 (13) 0.100 ± 0.013 (12) 26.7/27.9 g
AQP1 KO 0.053 ± 0.009p2 (12) 0.142 ± 0.053p1(12) 0.087 ± 0.009p3 (12) 25.6/25.9 g
Rhag WT 0.071 ± 0.025 (8) 0.132 ± 0.016 (8) 0.081 ± 0.015 (8) 28.4/28.6 g
Rhag KO 0.077 ± 0.013ns (7) 0.142 ± 0.010ns (7) 0.086 ± 0.020ns (7) 28.6/28.9 g
AQP1-Rhag WT 0.068 ± 0.012 (15) 0.151 ± 0.025 (15) 0.093 ± 0.015 (15) 26.7/27.4 g
AQP1-Rhag DKO 0.050 ± 0.012p5 (14) 0.130 ± 0.026p4(14) 0.082 ± 0.017ns (14) 26.8/26.2 g
AQP9 WT 0.072 ± 0.018 (13) 0.137 ± 0.014 (13) 0.090 ± 0.013(13) 30.7/30.0 g
AQP9 KO 0.063 ± 0.018ns (14) 0.133 ± 0.018ns(14) 0.090 ± 0.014ns (14) 30.8/31.5 g
V˙O2,rest are measurements of mice at rest in air at 20–24
◦C, V˙O2,max are measurements of maximal oxygen consumption in the presence of 79% He in the inspiratory gas. Means are
given together with SD. Numbers in brackets are number of animals studied. Body weights give on the left numbers for normoxia, on the right for hypoxia. Levels of significance are
given for KO- vs. WT-values: ns = not significantly different, p1 = 0.002, p2 = 0.02, p3 = 0.01, p4 = 0.03, p5 = 0.004. Each comparison is between one set of measurements with
WT and the corresponding one with KO (DKO) animals.
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TABLE 2 | Results of pulse oximetry in AQP1-KO and WT mice.
AQP1-WT Normoxia (N = 8) AQP1-KO Normoxia (N = 6) AQP1-WT Hypoxia (N = 9) AQP1-KO Hypoxia (N = 7)
SO2,a (%) [at V˙O2,max] 96.8 ± 1.1 96.9 ± 1.1
ns 64.2 ± 3.1 65.5 ± 2.2ns
HR (min−1) [at V˙O2,max] 770 ± 7 717 ± 28
ns 736 ± 11 677 ± 31ns
RR (min−1 ) [at V˙O2,max] 192 ± 13 168 ± 10
ns 197 ± 13 183 ± 20ns
SO2,a arterial oxygen saturation (taken above the carotid artery), HR heart rate, RR respiratory rate. All measurements were obtained in about the same time interval as the V˙O2,max
measurements, a few minutes after the start of exposure to a helium mixture (21% O2, 79% He in normoxia, 11% O2, 10% N2, 79% He in hypoxia). Given are means ± SD. Statistical
significances refer to comparisons of pairs of sets of KO- vs. WT-values (unpaired t-test). Levels of significance are from top down 0.92, 0.12, and 0.17 (3rd vs. 2nd column) and 0.73,
0.11 and 0.58 (5th vs. 4th column). Mean body weights were between 25 and 31 g.
argue against a diffusion limitation of peripheral O2 supply,
although direct evidence for this would have required knowledge
of venous O2 saturation.
The conclusion regarding the absence of diffusion limitation
in the periphery is in line with the distribution of AQP1 in the
lung and the periphery. Both in the lung and in skeletal muscle,
the exclusive or dominant site of expression is the capillary
endothelium. Thus, if lack of AQP1 causes no diffusion problem
in the lung, where AQP1 normally is most prominently expressed
(Nielsen et al., 1993), it is not likely that it will cause a problem in
heart and skeletal muscle.
Comparison of Resting vs. Maximal V˙O2
As explained above, increasing V˙O2 can—like exposure to
hypoxia—uncover a diffusion limitation. Thus, we ask, whether
in AQP1-deficient mice a reduction in V˙O2,max is seen (Table 1,
3rd column, lines 1 and 2, and lines 5 and 6) that is not seen
in V˙O2,rest (Table 1, 2nd column, lines 1 and 2, and lines 5
and 6). The data given here suggest that a reduction of V˙O2 is
present under resting conditions as well as under conditions of
maximal O2 consumption. Thus, no diffusion limitation would
become apparent here. However, the finding just described is
in clear contradiction to own previous observations obtained
with the same mice under anesthesia (Al-Samir et al., 2016).
The V˙O2-values of WT mice observed in this preceding study
were identical to those given in Table 2 for resting conditions.
However, there was no difference in V˙O2,rest between WT and
KO mice in this study. We believe it likely therefore that the
conscious AQP1-deficient mice of the present study exhibit a
lower V˙O2,rest than WT animals because of the known reduced
spontaneous physical activity of AQP1-deficient mice (Boron,
2010). Accordingly, basal V˙O2 of AQP-KO animals is likely to
be equal to that of WT animals, but V˙O2,max is reduced in KO
compared to WT animals. We consider it likely, nevertheless,
that this does not reflect a diffusion limitation but is caused by
the properties of the hearts of WT and KO animals, as explained
below.
Role of Red Cell Membranes as Barriers to O2
Diffusion
If AQP1, which is present in mouse as well as in human red
cells, would contribute to O2 transfer across the membrane,
the presence or absence of AQP1 could make a difference in
pulmonary as well as peripheral gas exchange. As discussed
above, the present results suggest that this is not the case. While
no measurements of the O2 permeability of mouse or human
red cells are available, such measurements have been reported for
CO2. Under the assumption that AQP1 is a channel for O2 as it is
for CO2 (Wang et al., 2007), the permeabilities measured for CO2
might be similar for O2. While AQP1 makes a major difference
for the CO2 permeability of human red cells (Endeward et al.,
2006a,b) as does RhAG (Endeward et al., 2008), this is not
so clear for mouse red cells. Yang et al. (2000) and Ripoche
et al. (2006) found no difference in CO2 permeability of the red
cells of mice either lacking AQP1 or Rhag. Own unpublished
measurements support this (T. Meine, S. Al-Samir, V. Endeward,
G. Gros). Thus, it seems possible that the red cell membranes
of the knockout mice have identical properties to those of WT,
and thus a differential contribution of KO and WT red cells to
peripheral and pulmonary gas exchange would indeed not be
expected.
Can the Heart of the AQP1-Deficient Mouse be
Responsible for Reduced V˙O2,max?
If we reject an interpretation of the present data in terms of
a diffusion problem, we are left with the known reduced left
ventricular weight and wall thickness of the KO animals (Montiel
et al., 2014; Al-Samir et al., 2016). This must be expected to
be associated with a reduced maximal cardiac output and thus
reduced V˙O2,max. Since in the preceding study we have shown
that cardiac function of AQP1-deficient animals under resting
conditions is entirely normal including stroke volume and heart
rate, this interpretation nicely explains why (normoxic) resting
V˙O2 under anesthesia is not reduced (cf. Al-Samir et al., 2016),
but (normoxic) V˙O2,max is impaired (Table 1, 3rd column), as
just discussed. It likewise explains satisfactorily why V˙O2,max is
reduced to the same extent in normoxia and hypoxia, as discussed
above.
We conclude that several lines of evidence argue against the
existence of an O2 diffusion problem in mice lacking AQP1.
This does not rule out that AQP1 acts as a pore for O2, but can
be due to a rather high background permeability of biological
membranes without AQP1. This would be in agreement with the
very high O2 permeabilities observed by Subczynski et al. (1989,
1992) in artificial phospholipid and in biological membranes.
If the basal O2 permeability of these membranes is so high,
O2 transfer across AQP1 would not noticeably increase O2
permeation across the membrane. This is quite in contrast to
what we and others have shown for the case of CO2 (Endeward
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et al., 2006a, 2008; Musa-Aziz et al., 2009; Itel et al., 2012), where
AQP1 generates a significant increase in CO2 permeability of
membranes containing a major fraction of cholesterol. Instead,
AQP1 deficiency obviously limits maximal oxygen consumption
by being associated with a reduced cardiac muscle mass and wall
thickness, which must be postulated to go along with a reduced
maximal cardiac output.
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